- Top FDA official threatens to crack down on vaccine approvals
A top FDA regulator called for tighter government vaccine oversight, including stricter guidelines for the annual flu shot and new vaccines, after an internal agency review linked COVID-19 vaccines to the deaths of 10 children
- More top vaccine regulators out at FDA, threatening new approvals
Experts say the exodus of top talent at the FDA’s Center for Biologics Evaluation and Research could hobble the agency’s ability to approve new vaccines and a wide range of other drugs —
- FDA vaccine official restricted COVID vaccine approvals against the . . .
WASHINGTON (AP) — The government’s top vaccine official working under Health Secretary Robert F Kennedy Jr recently restricted the approval of two COVID-19 vaccines, disregarding
- FDA vaccine official restricted COVID vaccine approvals against the . . .
The FDA's vaccine chief, Dr Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna
- Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation
Under leadership of Health Secretary Robert F Kennedy Jr, several public health agencies are downsizing and seeing layoffs, resignations, or firings—including the resignation of top FDA
- FDA tightens its leash on COVID vaccine approvals
FDA chief Marty Makary, M D and CBER head Vinay Prasad, M D , plan to require additional trials for COVID vaccines in healthy populations
- Vaccines Face Uncertain Approval, Reviews With New FDA Official
The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for those drugs presents a challenge for the pharmaceutical industry
- FDA Faces Leadership Exodus, Jeopardizing Future Vaccine Approvals
Following the recent resignation of Dr Peter Marks, the agency's top vaccine official, several other key regulators have either left or been forced out This sudden departure of top talent has raised concerns about the stability and future direction of the FDA's vaccine oversight
|